Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.
Messahel B, Ashley S, Saran F, Ellison D, Ironside J, Phipps K, Cox T, Chong WK, Robinson K, Picton S, Pinkerton CR, Mallucci C, Macarthur D, Jaspan T, Michalski A, Grundy RG; Children's Cancer Leukaemia Group Brain Tumour Committee. Messahel B, et al. Eur J Cancer. 2009 Jul;45(10):1815-23. doi: 10.1016/j.ejca.2009.03.018. Epub 2009 May 7. Eur J Cancer. 2009. PMID: 19427780
Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C, Pritchard-Jones K, Shannon R, Hutton C, Stevens S, Machin D, Imeson J, Kelsey A, Vujanic GM, Gornall P, Walker J, Taylor R, Sartori P, Hale J, Levitt G, Messahel B, Middleton H, Grundy R, Pritchard J; United Kingdom Cancer Study Group. Mitchell C, et al. Among authors: messahel b. Eur J Cancer. 2006 Oct;42(15):2554-62. doi: 10.1016/j.ejca.2006.05.026. Epub 2006 Aug 10. Eur J Cancer. 2006. PMID: 16904312 Clinical Trial.
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.
Messahel B, Williams R, Ridolfi A, A'hern R, Warren W, Tinworth L, Hobson R, Al-Saadi R, Whyman G, Brundler MA, Kelsey A, Sebire N, Jones C, Vujanic G, Pritchard-Jones K; Children's Cancer and Leukaemia Group (CCLG). Messahel B, et al. Eur J Cancer. 2009 Mar;45(5):819-26. doi: 10.1016/j.ejca.2009.01.005. Epub 2009 Feb 21. Eur J Cancer. 2009. PMID: 19231157 Clinical Trial.
Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.
Irtan S, Messahel B, Moroz V, Taylor RE, Grundy R, Kelsey A, Vujanic G, Pritchard-Jones K; Renal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG). Irtan S, et al. Among authors: messahel b. Radiother Oncol. 2019 Feb;131:1-7. doi: 10.1016/j.radonc.2018.10.026. Epub 2018 Dec 15. Radiother Oncol. 2019. PMID: 30773174 Clinical Trial.
23 results